Top

Published in:

01-10-2019 | Alopecia | Case report

Spironolactone

Vestibulodynia and female genital arousal disorder following an off-label treatment: 2 case reports

Published in: Reactions Weekly | Issue 1/2019

Excerpt

In a case series, a 47-year-old woman developed vestibulodynia and female genital arousal disorder following an off-label treatment with spironolactone for female pattern alopecia, and a 46-year-old woman developed vestibulodynia and female genital arousal disorder following an off-label treatment with spironolactone for acne [routes not stated; not all durations of treatments to reactions onsets stated]. …

Mitchell L, et al. Spironolactone May be a Cause of Hormonally Associated Vestibulodynia and Female Sexual Arousal Disorder. Journal of Sexual Medicine 16: 1481-1483, No. 9, Sep 2019. Available from: URL: http://doi.org/10.1016/j.jsxm.2019.06.012 - USA

Title: Spironolactone
Vestibulodynia and female genital arousal disorder following an off-label treatment: 2 case reports
Publication date: 01-10-2019
Publisher: Springer International Publishing
Keywords: Alopecia
Spironolactone
Dyspareunia
Acne
Testosterone
Estradiol
Published in: Reactions Weekly / Issue 1/2019
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-70123-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Spironolactone

Vestibulodynia and female genital arousal disorder following an off-label treatment: 2 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2019

Crizotinib/warfarin interaction

Pegvisomant

Baclofen

Linezolid/STAT3 transcription factor inhibitor interaction

Prednisone/rituximab

Contraceptives/erenumab/rizatriptan